文献速递儿科影像技术与安全CTMR

骨骼肌质量作为儿童及年轻癌症患者结局预测标志物的研究

Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer.
PubMed 文献 · Abdom Radiol (NY) · 2021-10-08

本研究回顾性分析了164例在辛辛那提儿童医院接受原发治疗的肿瘤患者,在诊断时于L3和L4椎体中部水平测量总腰大肌面积(tPMA),评估其与总生存期(OS)、无病生存期(DFS)及中性粒细胞减少天数的相关性。结果显示tPMA与中性粒细胞减少天数呈弱负相关,但与OS或DFS无显著相关性。

要点

  • 诊断时tPMA与中性粒细胞减少天数呈弱负相关,提示营养状态与细胞恢复可能相关。
  • tPMA与总生存期或无病生存期无显著相关性。
  • 亚组分析中,人体测量学特征与标准化中性粒细胞减少天数的相关性仅见于脑肿瘤患者。

诊断标准与关键数值

  • tPMA与中性粒细胞减少天数在L3水平呈显著弱负相关(r = -0.24,p < 0.002),在L4水平亦呈显著弱负相关(r = -0.25,p < 0.002)。
  • tPMA与标准化中性粒细胞减少天数在L3水平呈显著弱负相关(r = -0.18,p < 0.05),在L4水平亦呈显著弱负相关(r = -0.19,p < 0.02)。
  • tPMA与DFS或OS整体及亚组分析均无统计学显著关系。

临床应用与阅片要点

  • 在儿童及年轻肿瘤患者诊断时的横断面影像上测量L3/L4水平腰大肌面积可能有助于提示中性粒细胞减少风险,但预测生存结局的价值有限。

局限性

  • 本研究为单中心回顾性研究,tPMA由单一评估者测量。
  • 原文未报告tPMA测量的观察者内或观察者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Nutrition is an important outcome predictor in oncology patients including treatment response, physical disability, quality of life, and overall survival. Sarcopenia (loss of skeletal muscle mass and function) is a demonstrated marker of nutritional status in adults, but data are more limited in children. The purpose of this study was to evaluate whether total psoas muscle area (tPMA) measured at the time of cancer diagnosis predicts overall survival (OS), disease free survival (DFS), or number of days neutropenic.

METHODS: A retrospective study was performed. tPMA was measured at the L3 and L4 mid-lumbar vertebral body level by a single reviewer on cross-sectional imaging studies performed within 2 weeks of primary oncologic diagnosis for all oncology patients who received their primary therapy at Cincinnati Children's Hospital between 1/1/2000 and 12/31/2013. Spearman's correlation was used to assess the association between tPMA and OS, DFS, days neutropenic, and adjusted days neutropenic. Subanalysis was performed assessing the relationship of tumor type and age at diagnosis with each parameter.

RESULTS: 164 patients (median age 9.9 years; 89 M/75 F) were included in the study. Days neutropenic and normalized days neutropenic were significantly but weakly negatively correlated with tPMA at L3 (r = - 0.24, p < 0.002 and r = - 0.18, p < 0.05 respectively) and L4 (r = - 0.25, p < 0.002; and and r = - 0.19, p < 0.02 respectively). At subanalysis, the correlation between anthropometric features and normalized days neutropenic was only seen with brain tumors. There was no statistically significant relationship between sarcopenia at diagnosis and DFS or OS overall or in subanalysis.

CONCLUSION: There is a weak inverse relationship between days neutropenic and psoas muscle bulk in pediatric and young adult oncology patients suggesting a relationship between nutritional status and cell recovery. Measures of sarcopenia, however, did not correlate with DFS or OS.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. McBee MP, Woodhouse C, Trout AT, et al. Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer. Abdom Radiol (NY). 2021. PMID: 34625830. doi:10.1007/s00261-021-03301-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。